Huawei plans for more AI pharma tie-ups, says healthcare president

Economic Times TechAugust 27, 2026en

The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical ‌companies are ⁠investing in ⁠modelling tools and automated laboratories to shorten development timelines and improve ​efficiency.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Economic Times Tech — open it there to read it in full.

• Verktyg